MedPath

Evaluation of the effect of ajwain topical formulation in reducing chronic joint pains

Phase 2
Recruiting
Conditions
Osteoarthritis.
Primary generalized (osteo)arthritis
Registration Number
IRCT20160306026938N6
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Informed consent for taking part in the study
Age between 60-80 years old
Suffering from osteoarthritis pain in one or both knees
Having an acceptable cognitive ability based on a short cognitive test (AMT)

Exclusion Criteria

Having severe pain, Visual Analogue Scale (VAS) more than 90
History of any surgery related to this disease on the intended joint
Cancer (current or any time before) and obvious symptoms of neuropsychiatric disorders
Chronic use of opiates
Sever chronic diseases, such as insulin-dependent diabetes
Injection of analgesic within the joint in 30 days before the intervention or any programe for injection until the end of the intervention period

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain through visual and Likert measurements. Timepoint: At the beginning of the study (before the intervention), one week and one month after commencement of topical use of Trachyspermum ammi. Method of measurement: Ontario and Master Osteoarthritis Index and KOOS (knee osteoarthritis outcome) questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath